TP53 and invasive carcinoma: In detail, in colorectal cancer, TP53 mutations primarily occur during the transition from benign adenoma to invasive carcinoma, resulting in a very high mutation rate (approximately 60%) in invasive carcinoma (late-stage adenocarcinoma), while being relatively rare in the adenoma stage [24].